ADVANCEMENT OF A TISSUE OXYGENATION MEASUREMENT DEVICE AND EVALUATION OF GALECTIN-3 AS NOVEL NONINVASIVE PROGNOSTIC BIOMARKERS FOR MONITORING VCA REJECTION

The General Hospital Corporation

Investigators